title: Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns.
authors: Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, and Translational Lung Research Center Heidelberg (TLRCH), member of the German Center for Lung Research (DZL), Heidelberg, Germany kreuter@uni-heidelberg.de.
authors: Michael
authors: M
authors: Kreuter
authors: Dept of Pulmonary Medicine, Erasmus Medical Center, University Hospital Rotterdam, Rotterdam, The Netherlands.
authors: Marlies S
authors: MS
authors: Wijsenbeek
authors: Dept of Respiratory Medicine, Thomayer Hospital, Prague, Czech Republic.
authors: Martina
authors: M
authors: Vasakova
authors: Medical University Clinic, Canton Hospital Baselland and University of Basel, Liestal, Switzerland.
authors: Paolo
authors: P
authors: Spagnolo
authors: Firestone Institute for Respiratory Health, Dept of Medicine, Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
authors: Martin
authors: M
authors: Kolb
authors: Interstitial and Rare Lung Disease Unit, Ruhrlandklinik, University Hospital, University of Duisburg-Essen, Essen, Germany.
authors: Ulrich
authors: U
authors: Costabel
authors: Policy Analysis Inc. (PAI), Brookline, MA, USA.
authors: Derek
authors: D
authors: Weycker
authors: F. Hoffmann-La Roche Ltd, Basel, Switzerland.
authors: Klaus-Uwe
authors: KU
authors: Kirchgaessler
authors: National Institute for Health Research Biomedical Research Unit, Royal Brompton Hospital, London, UK.|Fibrosis Research Group, National Heart and Lung Institute, Imperial College, London, UK.
authors: Toby M
authors: TM
authors: Maher
mesh_terms: D000925:Anticoagulants; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis; D011658:Pulmonary Fibrosis
chemical_list: D000925:Anticoagulants